BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND SPECC1, FLJ36955, CYTSB, 92521, ENSG00000128487, Q5M775, NSP, HCMOGT-1 AND Diagnosis
2 results:

  • 1. breast cancer screening: Impact on care pathways.
    Lefeuvre D; Catajar N; Le Bihan Benjamin C; Ifrah N; De Bels F; Viguier J; Bousquet PJ
    Cancer Med; 2019 Jul; 8(8):4070-4078. PubMed ID: 31172693
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
    Defossez G; Quillet A; Ingrand P
    BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.